References
- Horby P, Huntley C, Davies N, Edmunds J, Ferguson N, Medley G, Calum Semple G. SAGE meeting report. January 21, 2021.
- Greaney AJ, Loes AN, Crawford KHD, et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021;29(3):463–476.e6. doi:https://doi.org/10.1016/j.chom.2021.02.003.
- Shen L, Maglinte DT, Ostrow D, et al. Children’s Hospital Los Angeles COVID-19 Analysis Research Database (CARD) – a resource for rapid SARS-CoV-2 genome Identification using interactive online phylogenetic tools. bioRxiv. 2020. doi:https://doi.org/10.1101/2020.05.11.089763
- Shen L, Dien Bard J, Biegel JA, et al. Comprehensive genome analysis of 6,000 USA SARS-CoV-2 isolates reveals haplotype signatures and localized transmission patterns by state and by country. Front Microbiol. 2020;11:573430. doi:https://doi.org/10.3389/fmicb.2020.573430. PMID: 33013809; PMCID: PMC7509426.
- Pandey U, Yee R, Shen L, et al. High prevalence of SARS-CoV-2 genetic variation and D614G mutation in pediatric patients with COVID-19. Open Forum Infect Dis. ofaa551.
- Truong TT, Ryutov A, Pandey U, et al. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv [Preprint]. 2021. Update in: EBioMedicine. 2021 Apr 26;67:103355. PMID: 33688673; PMCID: PMC7941650.
- Shen L, Bard JD, Triche TJ, et al. Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications. Emerg Microbes Infect. 2021: 1–24. doi:https://doi.org/10.1080/22221751.2021.1922097. Epub ahead of print. PMID: 33896413.
- Truong TT, Ryutov A, Pandey U, et al. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series. EBioMedicine. 2021;67:103355), doi:https://doi.org/10.1016/j.ebiom.2021.103355 Epub ahead of print. PMID: 33915337; PMCID: PMC8072072.
- Ryutov A, Gai X, Ostrow D, et al. Utility of viral whole-genome sequencing for institutional infection surveillance during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021: 1–2. doi:https://doi.org/10.1017/ice.2021.185. Epub ahead of print. PMID: 33866984.
- Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID's innovative contribution to global health. Glob Chall. 2017;1(1):33–46. doi:https://doi.org/10.1002/gch2.1018 PMID: 31565258; PMCID: PMC6607375.
- Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data - from vision to reality. Euro Surveill 2017 Mar 30;22(13):30494. PMID: 28382917; PMCID: PMC5388101.
- Katoh K, Misawa K, Kuma K, et al. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002;30(14):3059–3066. doi:https://doi.org/10.1093/nar/gkf436 PMID: 12136088; PMCID: PMC135756.
- Minh BQ, Schmidt HA, Chernomor O, et al. IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37(5):1530–1534. doi:https://doi.org/10.1093/molbev/msaa015. Erratum in: Mol Biol Evol. 2020 Aug 1;37(8):2461. PMID: 32011700; PMCID: PMC7182206.
- Sagulenko P, Puller V, Neher RA. Treetime: maximum-likelihood phylodynamic analysis. Virus Evol. 2018;4(1):vex042), doi:https://doi.org/10.1093/ve/vex042. PMID: 29340210; PMCID: PMC5758920.
- Ittisoponpisan S, Islam SA, Khanna T, et al. Can predicted protein 3D structures provide reliable insights into whether Missense variants Are disease associated? J Mol Biol. 2019;431(11):2197–2212. doi:https://doi.org/10.1016/j.jmb.2019.04.009 Epub 2019 Apr 14. PMID: 30995449; PMCID: PMC6544567. [Google Scholar].
- Cyranoski D. Alarming COVID variants show vital role of genomic surveillance. Nature. 2021;589(7842):337–338. doi:https://doi.org/10.1038/d41586-021-00065-4. PMID: 33452508.
- Walensky RP, Walke HT, Fauci AS. SARS-CoV-2 variants of concern in the United States-challenges and opportunities. JAMA. 2021; 325(11):1037. Epub ahead of print. PMID: 33595644
- Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021;593(7857):130–135. doi:https://doi.org/10.1038/s41586-021-03398-2. Epub 2021 Mar 8. PMID: 33684923.
- Wibmer CK, Ayres F, Hermanus T, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021 Apr;27(4):622–625. doi:https://doi.org/10.1038/s41591-021-01285-x. Epub 2021 Mar 2. PMID: 33654292.
- McCarthy KR, Rennick LJ, Nambulli S, et al. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021 Mar 12;371(6534):1139–1142. doi:https://doi.org/10.1126/science.abf6950. Epub 2021 Feb 3. PMID: 33536258; PMCID: PMC7971772.